CL2019002552A1 - Composition for the measurement, prevention or relief of skin aging using hapln1. - Google Patents
Composition for the measurement, prevention or relief of skin aging using hapln1.Info
- Publication number
- CL2019002552A1 CL2019002552A1 CL2019002552A CL2019002552A CL2019002552A1 CL 2019002552 A1 CL2019002552 A1 CL 2019002552A1 CL 2019002552 A CL2019002552 A CL 2019002552A CL 2019002552 A CL2019002552 A CL 2019002552A CL 2019002552 A1 CL2019002552 A1 CL 2019002552A1
- Authority
- CL
- Chile
- Prior art keywords
- hapln1
- aging
- skin
- composition
- expression
- Prior art date
Links
Abstract
LA PRESENTE DIVULGACIÓN SE REFIERE A PROTEÍNA HAPLN1 DE UN INDIVIDUO ENVEJECIDO. LA PROTEÍNA HAPLN1 PRESENTA EXPRESIÓN REDUCIDA CON EL ENVEJECIMIENTO, Y CUANDO SE ADMINISTRA, ES EXCELENTE SU EFECTO EN ALIVIAR Y REVERTIR EL ENVEJECIMIENTO DE LA PIEL INCLUYENDO ARRUGAS. POR TANTO, EXPLOTANDO LA DIFERENCIA EN LA EXPRESIÓN, SE PROPORCIONAN UNA COMPOSICIÓN DE BIOMARCADOR PARA MEDIR EL ENVEJECIMIENTO DE LA PIEL, CAPAZ DE DIAGNOSTICAR EL ENVEJECIMIENTO DE LA PIEL; UN KIT; Y UN MÉTODO DE BÚSQUEDA DE AGENTES DE ALIVIO DEL ENVEJECIMIENTO DE LA PIEL, QUE COMPRENDE DETECTAR EL NIVEL DE EXPRESIÓN DE PROTEÍNA HAPLN1 O GEN HAPLN1. ADEMÁS, SE PROPORCIONAN UNA COMPOSICIÓN FARMACÉUTICA, COMPOSICIÓN COSMÉTICA, O NUTRACÉUTICO, PARA PREVENIR O ALIVIAR EL ENVEJECIMIENTO DE LA PIEL, Y UNA COMPOSICIÓN COSMÉTICA O NUTRACÉUTICO PARA ALIVIAR ARRUGAS, CONTENIENDO CADA UNO UNA CUALQUIERA O MÁS SELECCIONADOS DEL GRUPO QUE CONSISTE EN PROTEÍNA HAPLN1, UN GEN QUE CODIFICA LA MISMA, Y UN AGENTE EFICAZ PARA PROMOVER LA EXPRESIÓN O ACTIVACIÓN DE LAS FUNCIONES DE PROTEÍNA O GEN HAPLN1.THIS DISCLOSURE REFERS TO HAPLN1 PROTEIN FROM AN AGED INDIVIDUAL. HAPLN1 PROTEIN EXPRESSES REDUCED EXPRESSION WITH AGING, AND WHEN ADMINISTERED, ITS EFFECT IN RELIEVING AND REVERSING SKIN AGING, INCLUDING WRINKLES, IS EXCELLENT. THEREFORE, EXPLOITING THE DIFFERENCE IN EXPRESSION, A BIOMARKER COMPOSITION IS PROVIDED TO MEASURE THE AGING OF THE SKIN, CAPABLE OF DIAGNOSING THE AGING OF THE SKIN; ONE KIT; AND A SEARCH METHOD FOR SKIN AGING RELIEF AGENTS, WHICH INCLUDES DETECTING THE LEVEL OF EXPRESSION OF HAPLN1 PROTEIN OR HAPLN1 GENE. IN ADDITION, A PHARMACEUTICAL COMPOSITION, COSMETIC OR NUTRACEUTIC COMPOSITION ARE PROVIDED TO PREVENT OR RELIEVE AGING OF THE SKIN, AND A COSMETIC OR NUTRACEUTIC COMPOSITION TO RELIEVE WRINKLES, CONTAINING MORE OF THE SELECTIVE PROBLEMS, CONTAINING IN EACH PROVIDED ONE A GENE THAT CODES THE SAME, AND AN EFFECTIVE AGENT TO PROMOTE THE EXPRESSION OR ACTIVATION OF THE FUNCTIONS OF PROTEIN OR HAPLN1 GENE.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CL2019002552A CL2019002552A1 (en) | 2019-09-05 | 2019-09-05 | Composition for the measurement, prevention or relief of skin aging using hapln1. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CL2019002552A CL2019002552A1 (en) | 2019-09-05 | 2019-09-05 | Composition for the measurement, prevention or relief of skin aging using hapln1. |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2019002552A1 true CL2019002552A1 (en) | 2020-01-03 |
Family
ID=69227777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2019002552A CL2019002552A1 (en) | 2019-09-05 | 2019-09-05 | Composition for the measurement, prevention or relief of skin aging using hapln1. |
Country Status (1)
Country | Link |
---|---|
CL (1) | CL2019002552A1 (en) |
-
2019
- 2019-09-05 CL CL2019002552A patent/CL2019002552A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Salzer et al. | Cathelicidin peptide LL-37 increases UVB-triggered inflammasome activation: possible implications for rosacea | |
CO2020009625A2 (en) | Fap inhibitor | |
BR112016024424A2 (en) | flexible rendering based on a rendering target in graphic rendering | |
BR122020006907B8 (en) | ANTI-KRAS SINGLE DOMAIN ANTIBODY AND ITS USE, IN VITRO METHODS FOR MEASURING SAID ANTIBODY LEVELS AND FOR DIAGNOSING A DISORDER MEDIATED BY AN INTRACELLULAR COMPONENT, ISOLATED POLYPEPTIDE, AND COMPOSITION COMPRISING SUCH ANTIBODY OR ISOLATED POLYPEPTIDE | |
CO2018009434A2 (en) | Dengue anti-virus ns1 protein monoclonal antibodies | |
CL2019000586A1 (en) | Compositions of non-protein clostridial toxins. | |
BR112018069849A2 (en) | kit, device and method for the detection of early pancreatic cancer or pancreatic cancer precursor lesion | |
BR112016012968A2 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH AGING | |
PE20170140A1 (en) | METHODS FOR TREATING CANCER WITH TIGIT INHIBITORS AND AGENTS AGAINST CANCER | |
BR112018005770A2 (en) | dynamic switching between late depth test and conservative depth test | |
CO2019009796A2 (en) | Composition for the measurement, prevention or relief of skin aging using hapln1 | |
BR112018073460A2 (en) | combined therapies using farnesoid x receptor (fxr) modulators | |
BR112017023391A2 (en) | "composition, method for preparing a composition and methods for improving skin hydration" | |
MX2020004837A (en) | Adenosine pathway inhibitors for cancer treatment. | |
BR112018006349A2 (en) | pixel block level granularity graphics processing unit preemption | |
CR20150603A (en) | METALOPROTEINASE OF THE MATRIX AND USES OF THE SAME | |
AR105350A1 (en) | CLEANING COMPOSITION WITH PROPELLENT | |
Shiba et al. | Differential roles of MMP-9 in early and late stages of dystrophic muscles in a mouse model of Duchenne muscular dystrophy | |
AR102037A1 (en) | PROCESSOR AND METHOD FOR THE PROCESSING OF AN AUDIO SIGNAL BY THE USE OF THE TRUNCATED ANALYSIS OR THE SOLUTION PORTIONS OF THE SYNTHESIS WINDOW | |
BR112017004883A2 (en) | rgma fragment-based diagnostic assay | |
BR112018073355A2 (en) | fat and its medical uses | |
CL2014001150A1 (en) | System and method where the system is particularly a mobile device, for the determination of solute concentration in a colored liquid sample, which is based on obtaining images of the sample and known concentration patterns of the solute, and determining of the concentration of the sample based on the processing of these images and the color values that they provide | |
CO2020008863A2 (en) | Biomarkers of immune tolerance induced by methotrexate | |
CL2019002552A1 (en) | Composition for the measurement, prevention or relief of skin aging using hapln1. | |
BR112019003688A2 (en) | formulations for edible bubble solution |